Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 27, 2014-09 ,pp. : 3173-3187

Bentham Science Publishers

Access to resources Recommend Favorite

Protective effect of urantide against ischemia–reperfusion injury via protein kinase C and phosphtidylinositol 3′-kinase – Akt pathway

By Zhang Jun-Yan   Chen Zhi-Wu   Yao Hua  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 5, 2012-05 ,pp. : 637-645

NRC Research Press

Access to resources Recommend Favorite

The phosphoinositide 3-kinase signalling pathway as a therapeutic target in squamous cell carcinoma of the head and neck

By Rogers Susanne J   Box Carol   Harrington Kevin J   Nutting Chris   Rhys-Evans Peter   Eccles Suzanne A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 769-790

Informa Healthcare

Access to resources Recommend Favorite

Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 6, 2007-09 ,pp. : 591-604

Bentham Science Publishers

Access to resources Recommend Favorite

Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury

By WangJun   JiShu-Yun   LiuSi-Zhu   JingRui   LouWei-Juan  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 9, 2015-09 ,pp. : 593-597

Govi-Verlag

Access to resources Recommend Favorite